Possibility of osteopathic correction in the complex therapy of patients with Parkinson′s disease

Introduction. Parkinson′s disease (PD) is a slowly progressive chronic disease and currently all available treatments are aimed at alleviating the symptoms of the disease and improving the quality of patients′ life. The main correction is drug therapy. Taking into account the progressive nature of the disease, the insuffi cient effectiveness of drug therapy, as well as early and frequent complications from drug therapy, the search for new pathogenetic and symptomatic drugs, as well as additional non-drug methods of treatment, is constantly being conducted. A number of authors have also previously demonstrated positive changes in the state of motor functions and regression of some neurological manifestations in PD patients with the use of certain osteopathic correction techniques. The above suggests that osteopathic correction may become one of the new directions in the treatment of PD within the framework of complex therapy.
The aim of the study is to substantiate the possibility of the inclusion of osteopathic correction of patients with Parkinson′s disease in complex therapy.
Materials and methods. A controlled, randomized prospective study was carried out at the Bakhrushin Brothers City Clinical Hospital and the «Ear, Throat and Nose Clinic» (Moscow) medical center from April 2019 to January 2020. The study included 24 patients aged 60 to 78 years with a diagnosis of Parkinson′s disease stage I–II according to Hoehn and Yahr. Depending on the applied treatment method, the patients were divided by simple randomization into two comparable groups (main and control) of 12 people each. All observed patients received common drug therapy and exercise therapy. Additionally, the patients of the main group underwent osteopathic correction (within 3 months, once every 14 days, a total of 6 sessions were performed). All patients, regardless of the group, underwent an osteopathic examination before and after treatment, with the formulation of an osteopathic conclusion; the quality of life was assessed according to the Medical Outcomes Study 36-Item Short-Form Health Survey, and the impact of motor and non-motor symptoms of PD on the daily activity of patients was assessed using the unifi ed PD assessment scale of the International Society of Movement Disorders (MDS UPDRS).
Results. The use of osteopathic correction together with drug therapy in PD patients leads to a statistically signifi cant (p<0,05) improvement in quality of life indicators (vitality scale and physical health scale) and daily physical activity (depression level). There is also a change in the structure of the dominant somatic dysfunctions (SD) in the form of a signifi cant decrease in the number of global SD.
Conclusion. To increase the effectiveness of complex therapy for patients with PD, the common drug therapy can be supplemented with osteopathic methods of correction.

1. Левин О. С., Артемьев Д. В., Бриль Е. В., Кулуа Т. К. Болезнь Паркинсона: современные подходы к диагностике и лечению. Практич. мед. 2017; 1 (102): 45–48. [Levin O. S., Artemiev D. V., Bril E. V., Kulua T. K. Parkinson′s disease: modern approaches to diagnosis and treatment. Pract. Med. 2017; 1 (102): 45–48 (in russ.)].

2. Болезнь Паркинсона и расстройства движений: Рук. для врачей по материалам IV Национального конгресса по болезни Паркинсона и расстройствам движений / Под ред. С. Н. Иллариошкина, О. С. Левина. М.; 2007; 381 с. [Parkinson′s disease and movement disorders: A guide for physicians by the materials of the IV National Congress on Parkinson′s Disease and Movement Disorders / Eds. S. N. Illarioshkin, O. S. Levin. M.; 2007; 381 p. (in russ.)].

3. Яхно Н. Н., Нодель М. Р. Современные принципы терапии болезни Паркинсона. Рус. мед. журн. 2000; (10): 418. [Yakhno N. N., Nodel M. R. Modern principles of therapy for Parkinson′s disease. Russ. Med. J. 2000; (10): 418 (in russ.)].

4. Левин О. С., Федорова Н. В. Болезнь Паркинсона. М.: МЕДпресс-информ; 2012; 352 с. [Levin O. S., Fedorova N. V. Parkinson′s disease. M.: MEDpress-inform; 2012; 352 p. (in russ.)].

5. Экстрапирамидные расстройства: Рук. по диагностике и лечению / Под ред. В. Н. Штока, И. А. Ивановой-Смоленской, О. С. Левина. М.: Медпресс-информ; 2002; 608 с. [Extrapyramidal Disorders: A Guide for Diagnosis and Treatment / Eds. V. N. Shtock, I. A. Ivanova-Smolenskaya, O. S. Levin. M.: Medpress-inform; 2002; 608 p. (in russ.)].

6. Корнюхина Е. Ю. Методы медицинской реабилитации болезни Паркинсона. Физиотер., бальнеол. и реабилитация. 2013; (4): 21–25. [Kornyukhina E. Yu. The methods for the medical rehabilitation of Parkinson′s disease. Russ. J. Physiother. Balneol. Rehab. 2013; (4): 21–25 (in russ.)].

7. Yao S. Effect of osteopathic manipulative medicine on motor function, balance, and neuroprotective serum markers in Parkinson disease (pilot study). New York: Institute of Technology; 2017-current. Accessed March 16, 2021. https://www.nyit.edu/bio/syao

8. Wells M. R., Giantinoto S., D′Agate D., Areman R. D., Fazzini E. A., Dowling D., Bosak A. Standard osteopathic manipulative treatment acutely improves gait performance in patients with Parkinson′s disease. J. Osteopath. Med. 1999; 99 (2): 92–98. https://doi.org/10.7556/jaoa.1999.99.2.92

9. Lopez D., King H. H., Knebl J. A., Kosmopoulos V., Collins D., Patterson R. M. Effects of comprehensive osteopathic manipulative treatment on balance in elderly patients: a pilot study. J. Amer. Osteopath. Ass. 2011; 111 (6): 382–388. https://doi.org/10.7556/jaoa.2011.111.6.382

10. DiFrancisco-Donoghue J., Apoznanski T., de Vries K., Jung M. K., Mancini J., Yao S. Osteopathic manipulation as a complementary approach to Parkinson′s disease: A controlled pilot study. NeuroRehabilitation. 2017; 40 (1): 145–151. https://doi.org/10.3233/nre-161400

11. Muller T., Pietsch A. Comparison of gait training versus cranial osteopathy in patients with Parkinson′s disease: A pilot study. NeuroRehabilitation. 2013; 32 (1): 135–140. https://doi.org/10.3233/nre-130830

12. Effect of osteopathic manipulative medicine on Parkinsone disease. ClinicalTrials.gov Identifi er: NCT 020107638. 2014. Accessed March 16, 2021. https://www.clinicaltrials.gov/ct2/show/NCT02107638

13. Мохов Д. Е., Белаш В. О., Кузьмина Ю. О., Лебедев Д. С., Мирошниченко Д. Б., Трегубова Е. С., Ширяева Е. Е., Юшманов И. Г. Остеопатическая диагностика соматических дисфункций: Клинические рекомендации. СПб.: Невский ракурс; 2015; 90 с. [Mokhov D. E., Belash V. O., Kuzmina Ju. O., Lebedev D. S., Miroshnichenko D. B., Tregubova E. S., Shirjaeva E. E., Yushmanov I. G. Osteopathic diagnosis of somatic dysfunctions: Clinical recommendations. St. Petersburg: Nevskij rakurs; 2015; 90 p. (in russ.)].

14. Мохов Д. Е., Аптекарь И. А., Белаш В. О., Литвинов И. А., Могельницкий А. С., Потехина Ю. П., Тарасов Н. А., Тарасова В. В., Трегубова Е. С., Устинов А. В. Основы остеопатии: Учеб. для ординаторов. М.: Геотар; 2020; 400 с. [Mokhov D. E., Aptekar I. A., Belash V. O., Litvinov I. A., Mogelnitsky A. S., Potekhina Yu. P., Tarasov N. A., Tarasova V. V., Tregubova E. S., Ustinov A. V. The basics of osteopathy: A textbook for residents. M.: Geotar; 2020; 400 p. (in russ.)].

15. Brown P. Oscillatory nature of human basal ganglia activity: relationship to the pathophysiology of Parkinson′s disease. Mov Disord. 2003; 18 (4): 357–363. https://doi.org/10.1002/mds.10358

16. Маньковский Н. Б., Карабань И. Н., Карасевич Н. В. Болезнь Паркинсона: патогенетические аспекты лекарственной терапии и клинического течения. Журн. неврол. ім. Б. М. Маньковського. 2013; (1): 9–17. [Mankowskiy N. B., Karaban I. N., Karasevich N. V. Parkinson′s disease: pathogenetic aspects of drug therapy and clinical course. J. Neurol. im. B. M. Mankowskiy. 2013; (1): 9–17 (in russ.)].

17. Ware J. E., Snow K. K., Kosinski M., Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Lincoln, RI: Quality Metric Inc; 1993; 316 p.

18. Потёмина Т. Е., Кузнецова С. В., Перешеин А. В., Самойлова О. Ю., Янушанец О. И. Качество жизни в здравоохранении: критерии, цели, перспективы. Российский остеопатический журнал. 2018; 3–4 (42–43): 98–106. [Potemina T. E., Kuznetsova S. V., Pereshein A. V., Samoilova O. J., Yanushanets O. I. Quality of life in healthcare services: criteria, goals, prospects. Russian Osteopathic Journal. 2018; 3–4 (42–43): 98–106 (in russ.)]. https://doi.org/10.32885/2220-0975-2018-3-4-98-106

19. Ненашкина Э. Н. Влияние остеопатической коррекции на психоэмоциональное состояние и качество жизни беременных с сопутствующей патологией мочевыводящей системы. Российский остеопатический журнал. 2020; (1–2): 66–74. [Nenashkina E. N. Infl uence of osteopathic correction on the psychoemotional state and quality of life of pregnant women with concomitant pathology of the urinary system. Russian Osteopathic Journal. 2020; (1–2): 66–74 (in russ.)]. https://doi.org/10.32885/2220-0975-2020-1-2-66-74

20. Мохов Д. Е., Черняга С. А. Исследование влияния остеопатической техники дренажа венозных синусов на венозный отток из полости черепа. Российский остеопатический журнал. 2014; 3–4 (26–27): 58–65. [Mokhov D. E., Chernyaga S. A. Investigation of infl uence of osteopathic technique venous sinus drainage on the venous outfl ow from the cranial cavity. Russian Osteopathic Journal. 2014; 3–4 (26–27): 58–65 (in russ.)].

21. Белаш В. О., Мохов Д. Е., Трегубова Е. С. Остеопатическая коррекция в комплексной терапии и реабилитации пациентов с синдромом позвоночной артерии. Вопр. курортол., физиотер. и ЛФК. 2018; 95 (6): 34–43. [Belash V. O., Mokhov D. E., Tregubova E. S. The use of the osteopathic correction for the combined treatment and rehabilitation of the patients presenting with the vertebral artery syndrome. Probl. Balneol. Physiother. Exercise Ther. 2018; 95 (6): 34–43 (in russ.)]. https://doi.org/10.17116/kurort20189506134

22. Degenhardt B. F., Darmani N. A., Johnson J. C., Towns L. C., Rhodes D. C., Trinh C., McClanahan B., DiMarzo V. Role of osteopathic manipulative treatment in altering pain biomarkers: a pilot study. J. Amer. Osteopath. Ass. 2007; 107 (9): 387–400.

23. McPartland J. M., Giuffrida A., King J., Skinner E., Scotter J., Musty R. E. Cannabimimetic effects of osteopathic manipulative treatment. J. Amer. Osteopath. Ass. 2005; 105 (6): 283–291.

24. Panikashvili D., Simeonidou C., Ben-Shabat S., Hanus L., Breuer A., Mechoulam R., Shohami E. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature. 2001; 413 (6855): 527–531. https://doi.org/10.1038/35097089

25. Panikashvili D., Mechoulam R., Beni S. M., Alexandrovich A., Shohami E. CB1 cannabinoid receptors are involved in neuroprotection via NF-κB inhibition. J. Cereb. Blood Flow Metab. 2005; 25 (4): 477–484. https://doi.org/10.1038/sj.jcbfm.9600047

26. Mackie K. Cannabinoid receptors as therapeutic targets. Ann. Rev. Pharmacol. Toxicol. 2006; 46 (1): 101–122. https://doi.org/10.1146/annurev.pharmtox.46.120604.141254